The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
A novel tracer for positron emission tomography (PET) myocardial perfusion imaging, called flurpiridaz F-18, performed well in a second phase III trial when it came to the detection of CAD in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback